QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 284 filers reported holding QIAGEN NV in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $260,415 | -6.4% | 6,430 | +4.1% | 0.00% | 0.0% |
| Q2 2023 | $278,239 | -8.6% | 6,179 | -6.8% | 0.00% | 0.0% |
| Q1 2023 | $304,561 | -5.4% | 6,631 | +2.7% | 0.00% | -33.3% |
| Q4 2022 | $321,959 | +43.1% | 6,456 | +18.5% | 0.00% | +50.0% |
| Q3 2022 | $225,000 | -16.4% | 5,450 | -4.2% | 0.00% | 0.0% |
| Q2 2022 | $269,000 | +11.2% | 5,690 | +13.6% | 0.00% | 0.0% |
| Q2 2021 | $242,000 | +9.0% | 5,010 | +9.9% | 0.00% | 0.0% |
| Q1 2021 | $222,000 | -11.2% | 4,559 | -3.6% | 0.00% | 0.0% |
| Q4 2020 | $250,000 | -62.1% | 4,729 | -76.8% | 0.00% | -50.0% |
| Q1 2018 | $660,000 | +105.0% | 20,400 | +96.2% | 0.00% | 0.0% |
| Q4 2017 | $322,000 | +7.3% | 10,400 | +9.5% | 0.00% | 0.0% |
| Q3 2017 | $300,000 | +6.4% | 9,500 | +13.1% | 0.00% | 0.0% |
| Q2 2017 | $282,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |